US Stock MarketDetailed Quotes
AXIM AXIM BIOTECHNOLOGIES INC
- 0.014300
- +0.000470+3.40%
15min DelayClose Jul 9 16:00 ET
4.17MMarket Cap-510P/E (TTM)
0.014700High0.013950Low213.65KVolume0.013950Open0.013830Pre Close3.07KTurnover0.10%Turnover RatioLossP/E (Static)291.46MShares0.03490052wk High-0.55P/B3.10MFloat Cap0.00500052wk Low--Dividend TTM216.91MShs Float1.220000Historical High--Div YieldTTM5.42%Amplitude0.005000Historical Low0.014000Avg Price1Lot Size
AXIM BIOTECHNOLOGIES INC Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 616.22%52.98K | 345.27%39.52K | 70.07%12.86K | 629.15%9.58K | 9.93K | 7.4K | -85.32%8.88K | 57.23%7.56K | -83.83%1.31K | 0 |
| Operating revenue | 616.22%52.98K | 345.27%39.52K | 70.07%12.86K | 629.15%9.58K | --9.93K | --7.4K | -85.32%8.88K | 57.23%7.56K | -83.83%1.31K | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -36.31%457.34K | -40.14%2.79M | -33.32%766.8K | -54.66%598.12K | -33.23%707.66K | -36.62%718.03K | -40.15%4.66M | -31.79%1.15M | -59.11%1.32M | -48.70%1.06M |
| Selling and administrative expenses | -43.51%333.84K | -45.18%2.24M | -37.54%623.67K | -61.39%456.65K | -38.30%566.83K | -39.84%590.94K | -27.99%4.08M | 16.69%998.48K | -53.06%1.18M | -38.75%918.71K |
| Research and development costs | -23.81%15.5K | -18.35%125.5K | -18.47%36.37K | 16.79%34.71K | -3.12%34.07K | -53.98%20.34K | -46.05%153.7K | -34.96%44.61K | -55.81%29.72K | -26.83%35.17K |
| Depreciation amortization depletion | 1.17%108.01K | 0.21%427.02K | -0.08%106.76K | 0.01%106.76K | 0.70%106.76K | 0.21%106.76K | -79.86%426.13K | -85.97%106.84K | -84.75%106.74K | -83.64%106.01K |
| -Depreciation and amortization | 1.17%108.01K | 0.21%427.02K | -0.08%106.76K | 0.01%106.76K | 0.70%106.76K | 0.21%106.76K | -79.86%426.13K | -85.97%106.84K | -84.75%106.74K | -83.64%106.01K |
| Operating profit | 43.10%-404.36K | 40.88%-2.75M | 34.00%-753.94K | 55.34%-588.54K | 34.17%-697.73K | 37.28%-710.63K | 39.80%-4.65M | 32.04%-1.14M | 59.05%-1.32M | 48.32%-1.06M |
| Net non-operating interest income expense | -140.49%-223.68K | 35.79%-1.2M | -78.36%-204.29K | -10.16%-114.48K | -616.56%-792.99K | 94.03%-93.01K | -152.76%-1.88M | 66.95%-114.54K | -41.96%-103.92K | 54.01%-110.67K |
| Non-operating interest income | ---- | --0 | --0 | --0 | --0 | ---- | -74.95%257 | -99.61%1 | --0 | --0 |
| Non-operating interest expense | 140.49%223.68K | -35.79%1.2M | 78.36%204.29K | 10.16%114.48K | 616.56%792.99K | -94.03%93.01K | 286.23%1.88M | 28.22%114.54K | 41.46%103.92K | -54.06%110.67K |
| Other net income (expense) | 117.14%335.75K | -1,535.08%-4.1M | -363.79%-944K | 268.35%1.03M | -4,186.83%-2.23M | -424.35%-1.96M | 103.79%285.98K | 105.95%357.86K | -612.71K | 96.61%-52.08K |
| Gain on sale of security | 115.68%334.35K | -522.15%-3.23M | -73.74%91.08K | 307.91%1.04M | -771.29%-2.23M | -463.11%-2.13M | --765.56K | --346.79K | ---500.89K | --332.58K |
| Special income (charges) | -96.29%6.4K | -65.19%-792.19K | -8,728.48%-955K | 91.13%-9.92K | ---- | 921.84%172.73K | 93.65%-479.57K | 100.18%11.07K | ---111.82K | 74.95%-384.66K |
| -Less:Other special charges | 96.29%-6.4K | 65.19%792.19K | 8,728.48%955K | -91.13%9.92K | ---- | -921.84%-172.73K | -69.78%479.57K | -121.38%-11.07K | --111.82K | -74.95%384.66K |
| Other non- operating income (expenses) | ---5K | ---80.08K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 89.42%-292.3K | -29.10%-8.06M | -111.58%-1.9M | 116.14%328.47K | -204.53%-3.72M | -32.39%-2.76M | 61.04%-6.24M | 88.83%-899.05K | 38.19%-2.03M | 68.05%-1.22M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 89.42%-292.3K | -29.10%-8.06M | -111.58%-1.9M | 116.14%328.47K | -204.53%-3.72M | -32.39%-2.76M | 61.06%-6.24M | 88.83%-899.05K | 38.19%-2.03M | 68.05%-1.22M |
| Net income continuous Operations | 89.42%-292.3K | -29.10%-8.06M | -111.58%-1.9M | 116.14%328.47K | -204.53%-3.72M | -32.39%-2.76M | 61.04%-6.24M | 88.83%-899.05K | 38.19%-2.03M | 68.05%-1.22M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 89.42%-292.3K | -29.10%-8.06M | -111.58%-1.9M | 116.14%328.47K | -204.53%-3.72M | -32.39%-2.76M | 61.06%-6.24M | 88.83%-899.05K | 38.19%-2.03M | 68.05%-1.22M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 89.42%-292.3K | -29.10%-8.06M | -111.58%-1.9M | 116.14%328.47K | -204.53%-3.72M | -32.39%-2.76M | 61.06%-6.24M | 88.83%-899.05K | 38.19%-2.03M | 68.05%-1.22M |
| Basic earnings per share | 92.31%-0.001 | 0.00%-0.04 | -116.67%-0.013 | 108.33%0.001 | -100.00%-0.02 | -30.00%-0.013 | 66.67%-0.04 | 90.00%-0.006 | 60.00%-0.012 | 66.67%-0.01 |
| Diluted earnings per share | 92.31%-0.001 | 0.00%-0.04 | -116.67%-0.013 | 105.83%0.0007 | -100.00%-0.02 | -30.00%-0.013 | 66.67%-0.04 | 90.00%-0.006 | 60.00%-0.012 | 66.67%-0.01 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg